Sources | Names Used |
---|---|
CCLE, GDSC1000, GRAY, FIMM | Sorafenib |
CTRPv2 | sorafenib |
PharmacoGx | Sorafenib |
Database | Identifier |
---|---|
Smiles: | CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F |
Inchikey: | MLDQJTXFUGDVEO-UHFFFAOYSA-N |
Pubchem: | 216239 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CXorf21 | CCLE | pan-cancer | AAC | 0.28 | 0.0001 |
mRNA | IRAK3 | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | MMRN1 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
mRNA | TMEM233 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
mRNA | TMEM104 | GDSC1000 | pan-cancer | AAC | 0.2 | 0.0001 |
mRNA | H6PD | CCLE | pan-cancer | AAC | 0.18 | 0.0001 |
mRNA | FAM161A | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0001 |
mRNA | STAC3 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0001 |
mRNA | RAB39B | GDSC1000 | pan-cancer | AAC | -0.23 | 0.0001 |
mRNA | CSF2RA | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |